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Abstract
Background: Classical galactosemia (CG) is due to a severe deficiency of the galactose-1-phosphate uridyl-transferase
(GALT), the main enzyme of galactose metabolism. Even early introduction of galactose-restricted diet fails to prevent
long-term complications, including cognitive impairment, neurological and psychiatric problems, osteoporosis, premature
ovarian failure and infertility. Detailed neuropsychological phenotyping is needed in order to better understand the
relevant neurodevelopmental deficiencies and to develop effective treatment strategies.
Aim: To define specifically and significantly impaired neuropsychological traits in adult CG patients of the Swiss cohort.
Methods: Prospective cohort study. 22 CG patients, with confirmed genotype and low GALT activity, and 15 controls
completed a computer-based neuropsychological test battery (CANTAB). Additionally, broad IQ evaluation was made for
the CG patients.
Results: In most outcome measures of the CANTAB tasks, CG patients performed significantly worse than controls. The
deficits in CG patients were most prominent in tasks that involve rapid visual information processing and facial emotion
recognition.
Conclusion: CG patients have specific cognitive problems such as impaired visual information processing and facial
emotion recognition. The deficits in facial emotion recognition have not been described before and could help explain
difficulties in social interactions often experienced by patients with CG.
Keywords: Classical galactosemia, CANTAB, Facial emotion recognition, Visual information processing, Neuropsychology,
Executive function, Sustained attention
Background
Classical galactosemia (CG; OMIM #230400) is a rare
disorder affecting the galactose metabolism. It is
autosomal-recessively inherited and caused by a pro-
found deficiency of the enzyme galactose-1-phosphate
uridyltransferase (GALT; EC 2.7.7.12) [1]. Together
with two other enzymes: galaktokinase (GALK) and
UDP-galactose epimerase (GALE), GALT is part of
the Leloir pathway that metabolizes ingested galactose
into glucose-1-phosphate used for energy and into
UDP-galactose which is used for glycosylation of
complex molecules. In untreated CG patients, galact-
ose, galactose-1-phosphate, galactitol and galactonate
accumulate in body tissues and fluids [2]. So far over
180 different mutations in the gene encoding for
GALT have been identified and associated with CG
[3]. Other mutations are known to cause only mild
deficiency, including the so-called Duarte-2 mutation
(N314D), the most common of them. Compound-heterozy-
gotes for a Duarte and a classical mutation normally have a
residual GALT activity of 14–25% and a good prognosis
without treatment [4].
Newborns with CG develop a life-threatening intoxica-
tion syndrome with acute liver failure, renal tubular
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dysfunction, sepsis and cerebral oedema. Symptoms
resolve within a few days after establishing a galactose-
restricted diet [1, 2]. Even when typical clinical signs of
galactosemia are present, the diagnosis may be missed.
In order to ensure rapid diagnosis and adequate man-
agement, newborns are screened for galactosemia in
many countries. Newborn screening can decrease the
morbidity and mortality caused by the acute complica-
tions of galactosemia in the neonatal period.
However, even strict adherence to the diet cannot pre-
vent the long-term complications that may occur in CG,
such as deficits in cognitive functions, speech and lan-
guage impairments and neurological deficits including
tremor and other extrapyramidal motor abnormalities,
as well as premature ovarian insufficiency and low bone
mineral density [1, 5, 6]. Most studies researching the
neuropsychological impairments have focused on global
measures of IQ, reporting overall IQ scores within the
low to below average range, with a great variability be-
tween individual patients [7–14]. The cognitive impair-
ments are thought to result from a broad set of deficits
[10]. Few other studies also described visual-perceptual
difficulties and less well-developed executive functions
[7, 12, 15]. Many of the patients suffer from speech and
language impairments [16, 17]. Higher incidence of psy-
chiatric disorders such as depression or anxiety and
problems with social interactions are also known in CG
[17]. The biomarker galactose-1-phosphate, correlates
only loosely with long-term neuropsychological and
motor outcome [5, 18, 19].
The exact pathomechanisms of these neuropsycho-
logical long-term impairments remain unclear. The
brain may already be damaged in utero, as elevated
levels of galactose-metabolites were found in foetuses
from the age of 20 weeks of gestation [20]. Others sug-
gested that the endogenous galactose production might
lead to a toxic accumulation of galactose metabolites
even when patients are on a galactose-restricted diet [1].
The currently prevalent theory is that abnormal galacto-
sylation of complex molecules, including myelin, may
contribute to the pathology [21, 22]. Neuroimaging
studies showed poor myelination and other white
matter abnormalities, as well as cerebral and cerebellar
atrophy [10, 23, 24].
In order to further characterize the neuropsychological
profile of adult patients with CG, especially aspects of
executive and visual perceptual functions, we used
selected tasks from the Cambridge Neuropsycho-
logical Test Automated Battery (CANTAB), a com-
puterized assessment tool. This battery is highly
standardised and easy to conduct, and the results
highly reproducible.
Results
Characteristics of patients, Duarte subjects and controls
(Table 1)
Twenty-two patients, i.e. 58% of the known Swiss CG
population ≥ 16 years of age, were enrolled in the study.
Thirteen (59%) were females. Mean age was 30 years
(SD 11), median 29, range 16–59 years. Of the 22 CG
Table 1 Characteristics of Patients, Duarte and Controls
Duarte Controls Patients p-value
n 3 15 22
Age: Mean (SD) 33.3 (3.2) 33.1 (11.7) 30.4 (11.1) 0.475
Median (range) 34.0 (32–37) 32.0 (21–61) 28.5 (16–60) 0.467
Gender = Female (%) 2 (66.7) 10 (66.7) 13 (59.1) 0.903
IQ: Mean (SD) 115 (15) - 77 (17) 0.028
Median (range) 108 (105–133) - 77 (40–112) 0.011
Education subjects (%)
• School without qualification 0 (0.0) 0 (0.0) 3 (13.6) 0.380
• School with qualification 0 (0.0) 0 (0.0) 2 (9.1) 0.645
• Vocational 0 (0.0) 9 (60.0) 15 (68.2) 0.872
• Undergraduate 1 (33.3) 1 (6.7) 2 (9.1) 1.000
• Postgraduate 2 (66.7) 5 (33.3) 0 (0.0) 0.015
Max. Education parents/ education controls (%) 0.383
• Vocational 0 (0.0) 9 (60.0) 11 (52.4) 0.792
• Undergraduate 2 (66.7) 1 (6.7) 5 (23.8) 0.397
• Postgraduate 1 (33.3) 5 (33.3) 5 (23.8) 0.737
SD standard deviation. p-values refer to comparison of patients with controls, significant values are in bold. The Student’s t-test was used for mean comparison
and the Wilcoxon rank-sum test for median comparison. Chi-squared test was used for categorical variables. See methods section for description of the levels
of education
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patients all except one were diagnosed through new-
born screening. Most of them nevertheless exhibited
symptoms of intoxication before treatment initiation.
All patients had two known classical mutations
(Q188R, K285 N, L195P, H319Q, A320T and M142K),
except two patients with one classical and one known
slightly milder (R258C) mutations and one patient
with the genotype Q188R/L264 V and residual GALT
activity of 1.5%. Mean IQ score of the CG patients
was 77 (SD 17), the median also 77, and the range 49
to 112. Comparison of patient and control groups did not
show significant differences concerning age (p = 0.475) and
gender (p = 0.903). The education levels of controls and the
parents of the patients were comparable (p = 0.383). But, as
expected, they differed significantly between patients and
controls (p = 0.028). The three subjects with mild “Duarte”
galactosemia were compound-heterozygous for a classical
and the Duarte-2 (N314D) mutations. They were clinically
normal.
Validation of controls
Mean Z-scores of controls were compared to the CAN-
TAB norms by one sample t-test. Overall, the control
group was comparable to the normative data cohort of
CANTAB (see Additional file 1: Table S1). We therefore
compared the test results of CG patients with the results
of our control group.
CANTAB testing
Table 2 presents the descriptive data for all measures of
the CANTAB. In the Motor Screening Task (MST), CG
patients did not show a significantly longer mean latency
or made more errors than controls. In the Paired Associ-
ates Learning (PAL) task, CG patients performed worse
compared to controls. They needed more trials and
made more errors until successful completion of a stage.
Patients also made more errors in the stage with six
shapes and needed more trials in total. However, none of
these measures reached significance in nonparametric
testing. In the Spatial Span (SSP) task, CG patients had a
significantly shorter span length, which means they
could remember shorter sequences than controls. Pa-
tients also made significantly more usage errors. These
errors are made when the subject selected a box that did
not change colour. In the Reaction Time (RTI) task, CG
patients performed equally well as controls in the
simple-choice part. In the five-choice part movement
time was slower for CG patients compared to controls,
again without reaching significance, because of the im-
portant variation and large overlap with controls. In the
Rapid Visual Information Processing (RVP) task, CG pa-
tients performed significantly worse in all but one out-
come measure. They were less likely to identify the
target sequence but did not have more false alarms than
controls (Fig. 1). The results of the Emotion Recognition
Task (ERT) are displayed in Fig. 2: Recognition of the
emotions happiness and sadness was not significantly
different between CG patients and controls. However,
CG patients had significantly lower percentages for the
recognition of the emotions anger, disgust, fear and sur-
prise. They also needed more time to answer than
controls.
Importance of outcome measures
A random forest model consisting of 5000 trees was
trained and validated on the CANTAB data to quantify
the relative importance of each outcome measure for the
discrimination of group membership (control vs. galac-
tosemia patients; Additional file 2: Figure S1). The
higher the MDA (mean decrease in accuracy) of a given
measure the more important its contribution to group
discrimination. Several global and individual outcome
measures of the ERT (including total number correct,
mean latency, as well as the emotions surprise and fear)
and RVP tasks were most important for group discrim-
ination. Bootstrap estimate of error rate: 35.14%.
Correlations
A priori significant correlations of ERT and RVP out-
come measures are shown in Table 3. When corrected
for multiple comparisons (p-value FDR), only three
measures, all from the ERT (total correct, recognition
of sadness and disgust), correlated significantly with the
overall IQ score of the patients but none with their
level of education. In contrast, no significant a priori
correlation at all was observed with the education of
controls (not shown) or the maximum education of the
patients’ parents. Note, that no correlation with IQ,
educational level or age was found for the ERT fear,
which was also important for group discrimination (see
above). Two outcome measures, PAL total errors at the
stage of six shapes and RTI five-choice reaction time
showed a significant correlation with the age of the
controls, but not with the age of patients (not shown).
No significant correlations between CANTAB outcome
measures and any biochemical marker, such as
galactose-1-phosphate or residual GALT activity (not
shown) were found.
Discussion
In this study, we aimed at deepening the neuropsycho-
logical phenotype of classical galactosemia patients by
administering a series of tasks from the Cambridge
Neuropsychological Test Automated Battery (CANTAB)
to a Swiss cohort of 22 adult CG patients. This cohort
represents 58% from totally 38 known patients in
Switzerland.
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Table 2 CANTAB results
Test Duarte Control Patients
Mean (SD) Median/range Mean (SD) Median/range Mean (SD) p-value Median/range p-value
Motor Screening Task (MOT)
1. Mean latency (ms) 628.5 (54.7) 647/567–672 803.8 (236.3) 727/524–1221 993.4 (284.0) 0.263 942/593–1560 0.150
2. Mean error 8.6 (4.6) 8.0/4.3–13.5 6.6 (1.9) 6.0/3.7–10.9 7.7 (2.1) 0.761 7.4/5.1–12.2 0.559
Paired Associates Learning (PAL)
1. First trial memory score 21.3 (6.4) 24/14–26 20.7 (3.1) 20/16–25 18.6 (4.4) 0.200 19/8–24 0.778
2. Total errors adjusted 6.3 (9.3) 2/0–17 7.4 (5.9) 6/2–22 23.0 (31.3) 0.145 16/2–148 0.105
3. Total errors 6 shapes 3.0 (5.3) 0/0–9 2.5 (2.7) 2/0–9 8.8 (11.5) 0.049 6/1–50 0.321
4. Mean errors to success 0.79 (1.16) 0.25/0.00–2.13 0.92 (0.73) 0.75/0.25–2.75 2.25 (1.84) 0.010 2.00/0.25–3.25 0.105
5. Mean trials to success 1.25 (0.33) 1.13/1.00–1.63 1.36 (0.25) 1.25/1.13–2.00 1.79 (0.59) 0.010 1.63/1.13–3.20 0.103
6. Stages completed at
first trial
7.0 (1.0) 7/6–8 6.1 (0.8) 6/5–7 5.7 (0.9) 0.263 6/4–7 0.778
7. Total trials adjusted 10.0 (2.6) 9/8–13 10.9 (2.0) 10/9–16 14.8 (6.4) 0.041 13/9–37 0.103
Spatial Span (SSP)
1. Span length 7.3 (0.6) 7/7–8 7.1 (1.2) 7/5–9 5.6 (1.3) 0.002 5.5/3–9 0.019
2. Relative errors 1.9 (0.4) 1.9/1.8–2.7 2.2 (0.7) 2.4/0.9–3.1 2.2 (0.7) 1.000 2.2/1.0–4.7 1.000
3. Relative usage errors 0.14 (0.01) 0.14/0.14–0.17 0.32 (020) 0.29/0.00–0.67 0.60 (0.39) 0.043 0.5/0.0–1.5 0.556
Reaction Time (RTI)
1. Mean simple reaction
time (ms)
310 (63) 295/255–379 316 (57) 300/254–459 360 (94) 0.320 335/266–594 0.623
2. Mean simple movement
time (ms)
337 (89) 355/240–415 403 (141) 376/254–757 472 (160) 0.320 426/292–955 0.568
3. Mean five-choice
reaction time (ms)
338 (65) 329/278–406 337 (60) 331/260–461 393 (123) 0.284 339/302–757 0.437
4. Mean five-choice
movement time (ms)
322 (64) 336/252–377 373 (87) 358/254–567 475 (151) 0.031 420/291–827 0.253
Rapid Visual Information Processing (RVP)
1. A’ score 0.946 (0.055) 0.962/0.884–0.991 0.927 (0.045) 0.930/0.858–1.000 0.835 (0.078) 0.002 0.837/0.677–0.972 0.009
2. Probability of hit 0.790 (0.211) 0.852/0.556–0.963 0.719 (0.178) 0.741/0.444–1.000 0.426 (0.220) 0.002 0.407/0.074–0.889 0.009
3. Mean latency (ms) 382 (54) 397/321–426 408 (101) 394/295–691 563 (179) 0.005 541/332–1070 0.019
4. Probability of false
alarm
0.004 (0.004) 0.003/0.000–0.008 0.005 (0.006) 0.004/0.000–0.019 0.020 (0.037) 0.409 0.008/0.000–0.162 0.434
5. Total correct
rejections
261 (12) 264/247–271 255 (10) 255/241–273 235 (17) 0.002 234/191–265 0.009
6. Total hits 21.3 (5.7) 23/15–26 19.4 (4.8) 20/12–27 11.5 (6.0) 0.002 11/2–24 0.009
Emotion Recognition Task (ERT)
1. Total number correct 134.3 (4.6) 137/129–137 120.0 (20.5) 124/81–143 85.8 (25.0) < 0.001 89/42–128 0.009
2. Percent correct 74.6 (2.6) 76.1/71.7–76.1 66.7 (11.4) 68.9/45.0–83.9 47.7 (13.9) < 0.001 49.4/23.3–71.1 0.009
3. Percent correct
(happiness shown)
88.9 (11.7) 90.0/76.7–100 80.9 (12.2) 83.3/50.0–93.3 76.1 (15.4) 0.701 78.3/33.3–100 1.000
4. Percent correct
(sadness shown)
80.0 (6.7) 80.0/73.3–86.7 66.9 (22.1) 66.7/23.3–93.3 51.8 (23.1) 0.145 56.7/0.0–86.7 0.360
5. Percent correct
(anger shown)
73.3 (8.8) 76.7/76.7–80.0 60.7 (10.3) 63.3/40.0–73.3 41.1 (18.0) 0.004 41.7/6.7–70.0 0.016
Korner et al. Orphanet Journal of Rare Diseases           (2019) 14:56 Page 4 of 10
In our cohort, we found the most robust deficits in facial
emotion recognition (ERT) and rapid visual information
processing (RVP). Most of the ERT and RVP outcome mea-
sures were correlated to overall IQ and education of the pa-
tients, much less to age. Apart from three instances (see
Table 3), these correlations were no longer significant when
the p-value was adjusted for multiple comparisons. Bad
performance could not be explained by comprehension
problems of the subjects with low IQ, since the recognition
of ‘happiness’ was not different between patients and con-
trols. Comparison of overall IQ and ERT performance in a
scatter plot is shown in Additional file 3: Figure S2.
The patients performed also worse on several other
outcome measures of the four other tasks, MOT, PAL,
Table 2 CANTAB results (Continued)
Test Duarte Control Patients
Mean (SD) Median/range Mean (SD) Median/range Mean (SD) p-value Median/range p-value
6. Percent correct
(disgust shown)
73.3 (12.0) 70.0/63.3–86.7 62.4 (18.0) 70.0/33.3–90.0 37.7 (26.0) 0.009 36.7/0.0–83.3 0.048
7. Percent correct
(fear shown)
63.3 (15.3) 66.7/46.7–76.7 53.8 (26.8) 60.0/6.7–93.3 28.2 (14.6) 0.005 26.7/3.3–63.3 0.048
8. Percent correct
(surprise shown)
68.9 (7.7) 73.3/60.0–73.3 75.3 (9.6) 76.7/66.7–96.7 51.1 (22.6) 0.006 50.0/13.3–93.3 0.016
9. Mean latency (ms) 1283 (447) 1210/875–1761 1616 (587) 1379/988–2988 2489 (922) 0.018 2275/1320–4437 0.019
CANTAB results from the six selected tasks with corresponding measures, expressed as means and standard deviation (SD), as well as medians and ranges of
Duarte subjects, controls and patients. p-values refer to comparisons between patients and controls. The Student’s t-test was used for mean comparison and the
Wilcoxon rank-sum test for median comparison. An adjusted p-value (FDR) was used throughout to account for multiple comparisons (see Methods). Significant
values (p < 0.05) are in bold
Fig. 1 Rapid visual information processing (RVP) is a measure of sustained attention. Subjects had to recognise target sequences of three digits
from numbers appearing in a pseudo-random sequence at a rate of 100 digits per minute. The number of total hits is significantly lower (** = p < 0.01)
in Galactosemia patients compared to controls, whereas the probability of false alarms is not different in both groups
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SSP and RTI. Probably due to the relatively small
number of participants, only the Spatial Span (SSP)
remained significant, when nonparametric testing and
for multiple testing adjusted p-values were used (see
Table 2).
To our best knowledge, this study is the first to examine
facial emotion recognition in CG patients using the ERT
of the CANTAB. Our results show that CG patients were
able to correctly identify the basic emotions happiness
and sadness but performed significantly worse on the
more complex emotions anger, fear, disgust and surprise.
Previous studies reported that CG patients have problems
with social interactions and that they exhibit internalizing
symptoms such as depression and anxiety [12, 17, 25]. In
other studies, children with CG were also described as shy
and withdrawn in social relationships [8, 26]. Interestingly,
there seems to be a gap between the parents view and the
patients’ self-perception of their emotional state: while the
parents report considerable psychosocial difficulties, the
patients themselves often fail to recognize them [12, 27].
Data concerning the patients’ behaviour and emotional
state was mostly collected by means of questionnaires
filled out by parents, teachers or patients themselves, but
so far, little is known about the neuropsychological basis
of the psychosocial impairment. Our results suggest that
patients with CG have difficulties reading the facial ex-
pressions of their opposite correctly and therefore may
not always react appropriately. Considering that the ERT
is based on photographs of people acting the target emo-
tions, it cannot be excluded that social conventions con-
cerning these emotions play a role in the difficulties of the
patients to recognize them. It is possible that CG patients
also have difficulties to express their emotions or even to
perceive and identify their own emotions. This could ex-
plain the differing opinions of parents and patients
NS NS * * * *
Fig. 2 Emotion Recognition Task (ERT). The participants had to recognise facial expressions of six different emotions presented for 200ms. Recognition of
basic emotions, such as happiness and sadness, was not significantly different between patients and controls, whereas emotions considered more
complex, including surprise, anger, disgust and fear, appeared significantly more difficult for patients than for controls. Percentage of correct recognition of
each of the six emotions listed. NS = not significant, * = p < 0.05
Table 3 Correlation of ERT and RVP with other patient
characteristics
ERT IQ EduS Age G1P
% correct 0.887* 0.705 −0.477
% correct (happiness) 0.667
% correct (sadness) 0.760* 0.587 −0.475
% correct (surprise) 0.646 0.616 −0.446
% correct (anger) 0.627 0.423
% correct (disgust) 0.778* 0.599 −0.451
% correct (fear)
Mean latency
RVP
A’ score 0.673 0.628
Probability of hit 0.600 0.576
Total correct rejections 0.726 0.645
Total hits 0.600 0.576
Probability of false alarm −0.527 0.576
Correlation coefficients of ERT and RVP measures with intelligence quotient
(IQ), patients (professional) educational level (EduS), age, and galactose-1-
phosphate (G1P). Only à priori significant correlations (p < 0.05) are shown. Where
no such correlation exists, the cell was left blank. Only three correlations, marked
with an asterisk (*), also have a significant p-value-FDR (< 0.05), which accounts
for multiple comparisons (method of Benjamini & Yekutieli)
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mentioned above. Importantly, these emotion recognition
deficits may also be related to the observation that many
galactosemia patients manifest autistic traits, but generally
without fulfilling the diagnostic criteria.
Deficits in emotion recognition have also been de-
scribed in other inborn errors of metabolism, such as
Wilson’s disease [28] and tyrosinemia type I [29]. As in
both studies different tests were used, conclusions by
comparing the results can only be drawn cautiously. In
the study with patients with Wilson’s disease, the most
significant deficit was found in recognizing “anger”,
while in our galactosemia patients, the most important
difficult emotion was “fear”. The authors argue that pa-
tients with Wilson’s disease tend to react more aggres-
sively to ambiguous social situations than healthy controls
[28]. In contrast, galactosemia patients, as mentioned be-
fore, tend to be shy and withdrawn. In tyrosinemia type I
patients, in turn, Van Ginkel and colleagues found less
specific and less pronounced deficits in emotion recogni-
tion [29]. Nevertheless, similar to our findings, these were
not completely explained by the correlation with IQ.
The RVP task revealed another weakness of CG pa-
tients. Our results showed that rapid visual information
processing, a measure of sustained attention, is impaired
in adult CG patients. Widhalm et al. postulated that ga-
lactosemic patients suffer from cognitive slowing and
evaluated this outcome by means of reaction time tasks
[30]. In their study, children with CG showed reduced
ability to sustain visual attention, as well as attention
deficits in central processing stages indicating a reduced
processing capacity. Additionally, they had a remarkable
impairment of information processing speed [30]. The
significantly longer mean latency of patients in our study
also suggests reduced velocity of visual information pro-
cessing. In a study from Taiwan, RVP was administered
to a relatively large cohort of adolescents with autism
spectrum disorders (ASD) [31]. Compared to healthy
controls, they performed significantly worse, even after
adjusting for full IQ. The authors propose that RVP could
serve as a trait marker for ASD. These findings are inter-
esting in two respects: first, RVP abnormality in galacto-
semia patients may be another link to autism as discussed
above for the ERT and second, this measure appears to be
independent of IQ, at least in the normal IQ range. To
our knowledge, no study has systematically investigated
the correlation of RVP performance with low full IQ.
In the study of Widhalm et al. the CG children also
performed significantly slower than controls on a task of
simple reaction time [30]. Our patients however per-
formed equally well in both measures of the simple-choice
part and the reaction time of the five-choice part of the
RTI. In contrast, the movement time in the five-choice
part was slower, although this difference only reached sig-
nificance when means were compared. This may be due
to poor visual-motor integration described by previous
studies [10, 32]. In addition, motor difficulties alone may
have an influence, as it is easier to learn a uniform move-
ment than an unpredictable one.
Results on PAL revealed problems with visual memory,
which is most likely due to impaired visual perception as
described by other researchers before [7, 15]. Reduced
working memory capacity seems to be involved, too, as
indicated by a significantly shorter span length of the
CG patients compared to the controls on the SSP task.
These findings are in line with previous studies reporting
working memory scores of CG patients in the low aver-
age range [12, 13]. Furthermore, a recent study per-
formed resting-state functional MRI on CG patients in
order to assess the organization of core processing
systems of the brain [33]. They found abnormalities
in networks linked to spatial orientation, attention,
sensory-motor integration and motor planning. In
addition, altered connectivity was found in networks
involved in visuospatial capacity and working memory.
The alterations correlated with some neurocognitive tests
which indicates a relation with the clinical phenotype [33].
Conclusions
In conclusion, our study showed that CG patients have im-
paired visual perception, sustained visual information pro-
cessing and visual-motor integration, thus confirming
findings of previous studies. More interestingly, however,
our study showed a deficit of facial emotion recognition in
CG patients. To our best knowledge, this is the first time
that this specific impairment has been demonstrated in the
context of CG. The difficulty to recognise emotions cor-
rectly may have a considerable impact on patients’ social
life. The selected CANTAB tasks proved useful to detect
specific deficits of CG patients. Especially the ERT and the
RVP appeared to be important for group discrimination.
They could therefore be used in future studies such as
functional MRI studies aiming to find neuronal correlates
of the cognitive long-term complications, as well as surro-
gate markers of efficacy for potential new treatments. Fi-
nally, the findings of this study could also help to design
programs for galactosemia patients aiming at the develop-
ment of effective strategies to cope with the everyday con-
sequences of these specific deficits in emotion recognition,
in visual information processing and sustained attention.
Methods
Subjects and controls
The current study was approved by the local Ethics
Committee and all subjects gave informed consent. The
International Galactosemia Registry of the European Ga-
lactosemia Network (EGN Registry) was implemented in
Switzerland in 2015, aiming at the inclusion of all CG
patients, most of whom have been diagnosed by
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new-born screening since the mid-1960ies. All 38 known
patients with CG in Switzerland who are ≥16 years of
age, were contacted and invited to participate in this
study. CG was defined by a known genotype of classical
galactosemia or a residual GALT enzyme activity below
10%. Some patients declined to participate in the study
because they did not feel well enough (n = 5). One of
these suffered from a second condition (Down’s syn-
drome) and three were born before newborn screening.
Others declined because they were not available, mainly
for professional reasons (n = 5). For the remaining, the
reason is not known (n = 6). The mean age of the
non-included patients was 35.3 years (SD 13.1; range
18–59). The final sample consisted of 22 CG patients
(59% females). Fifteen controls also completed the CAN-
TAB test battery. They were recruited from a laboratory,
administrative and medical staff. It was taken care that
their level of education was similar to the level of educa-
tion of the patient’s parents and male-female proportion
was close or identical to the patient cohort, in order to
reduce selection bias. In addition, three subjects with
mild “Duarte” galactosemia were enrolled. They under-
went identical testing as the patient group but were ana-
lysed separately. Due to their neuropsychological deficits,
patients with CG often achieve lower education than their
parents and non-affected siblings. In order to get a meas-
ure of the cognitive and psychosocial functioning of the
patient families and the controls, of which no full IQ
scores were available, we assessed and classified their level
of education, as well as of the patients, as follows: “School
without qualification”, i.e. either regular schooling not
completed or special needs schooling. “School with quali-
fication”, i.e. completed regular schooling and some add-
itional professional training. “Vocational”, i.e. full
professional education after obligatory school at age 16
and parallel to high school and college (this is the main
educational path in Switzerland, with a good professional
standing). “Undergraduate” and “Postgraduate” are the
two University levels of the European Bologna system.
Cognitive assessment
The study was part of a larger study conducted at the
University Hospital of Bern in Switzerland, which in-
cluded a full IQ assessment using the Wechsler Adult
Intelligence Scale, Fourth Edition (WAIS-IV). Six tasks
from the Cambridge Automated Neuropsychological
Test Battery (CANTAB) were administered to all sub-
jects including the controls in a session of approximately
60 min using German and French translations of the
standardised test instructions and a Windows Surface
touch-screen tablet. Thus, each task was explained to the
subjects in a thorough and standardized way, and it was
made sure that he/she had understood the instructions.
The following tasks were selected (see Additional
file 1: Table S2 for a description of the tests):
1. Motor Screening Task (MOT)
2. Paired Associates Learning (PAL)
3. Spatial Span (SSP)
4. Reaction Time (RTI)
5. Rapid Visual Information Processing (RVP)
6. Emotion Recognition Task (ERT)
For reference, see http://www.cambridgecognition.com/
cantab/cognitive-tests/ (Cambridge Cognition Ltd., 2017).
Statistical analysis
Baseline characteristics were presented in a descriptive
format, showing mean with standard deviation and me-
dian with range for age. The Student’s t-test was applied
for mean, the Wilcoxon rank-sum test for median com-
parison between patients and controls. Frequencies with
percentages were shown for categorical variables and the
Chi-Squared test was used for comparison. The one
sample t-tests was used to compare z-scores of controls
to CANTAB normative data. For the comparison of the
outcomes of the CANTAB sub-tests we again used the
t-test for mean and the Wilcoxon rank-sum test for me-
dian, as well as linear models to compute p-values cor-
rected for the influence of age, gender and the maximal
educations of parents. As multiple statistical tests were
performed, these p-values were adjusted using the
method of Benjamini and Yekutieli to reduce the false
discovery rate. The relative importance of outcome mea-
sures for predicting CG status was assessed by a random
forest model consisting of 5000 trees, implemented in
the randomForest R package. The random forest boot-
strap estimate of error rate was 35.14%. The Spearman
correlation was used and p-values were computed using
Spearman’s rho statistics. All analyses were performed in
version 3.4.1 of the R statistical environment.
Additional files
Additional file 1: Table S1: Comparison of controls to CANTAB normative
data. Table S2: CANTAB Tasks selected for the study. (DOCX 28 kb)
Additional file 2: Figure S1. Importance of individual CANTAB measures
to group discrimination. The measures were ranked according to the relative
importance of their contribution to distinguish between patients and controls.
The higher the MDA (mean decrease in accuracy) the more important. Thus,
the total number of emotions recognised correctly and the mean latency to
respond are the two most important variables. The recognition of surprise
(ERT-8) appears to be the emotion with the highest discriminative power
among the six emotions tested, followed by fear (ERT-7). The full names of the
outcome measures are listed in Table 2. (DOCX 61 kb)
Additional file 3: Figure S2. Scatter plot showing the correlation between
overall IQ and ERT performance of the patients. Note that the subjects with
the lowest IQ did not have the worst performance, suggesting that the latter
was not due to a failure to understand the instructions. (DOCX 38 kb)
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